Mel Reichman, PhD, a principal investigator at the Lankenau Institute for Medical Research (LIMR), was invited to serve as chairperson of the opening keynote session for the 2015 international joint conference of the European Chemical Biology Symposium (ECBS) and the International Chemical Biology Society (ICBS) held in Berlin, Germany, in October.
Dr. Reichman also gave the closing summary of the three-day conference that was attended by several hundred chemical biology researchers from around the globe. Additionally, he co-organized and co-chaired the session “Rising Stars in Chemical Biology,” an annual award session and ceremony for the three best presentations from young investigators in chemical biology worldwide.
Dr. Reichman founded and directs the LIMR Chemical Genomics Center, where he designed and built a patented automated repository and screening technology to help accelerate drug discovery. His current research focuses on developing and applying ultra-high throughput screening technologies to discover new drug synergies for treating diseases that have high unmet medical need, including neurodegeneration and diabetes complications.
He is an editor of several leading drug discovery journals, and serves as president and chairman of the board for the ICBS. Additionally, he has been named chair of the 2016 ECBS-ICBS conference to be held in Madison, Wisc.